IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
6
Neutral
4
Bullish
4
Bearish
9
Neutral
16
Bullish
21
Bearish
3
Neutral
12
Bullish
17
Bearish
3
Neutral
12
Bullish
17
Bearish
3
Neutral
12
Bullish
17
Bearish
3
Neutral
12
Bullish
17
Investor Presentation
Q1 FY27
Upcoming Result Date: Nov 13, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Manipal Health Enterprises Limited operates a national network of tertiary and quaternary hospitals, managing over fifty hospitals and more than 12,600 licensed beds across India, delivering high-acuity clinical services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics and renal sciences, while also offering diagnostics, outpatient clinics and digital healthcare capabilities.
In Q1 FY27 Manipal reported consolidated revenue of INR3,091 crores, a 38% year-on-year increase, with network EBITDA of INR749 crores (+26% YoY); ex-Sahyadri operating margin was about 25% while network margin was 24.2%, driven primarily by sustained inpatient volume growth (+39%) and outpatient volumes (+26%).
Digital and out-of-hospital initiatives contributed materially during the quarter: digital revenue was around INR710 crores (approximately 23% of overall revenue), e-pharmacy processed over 15,000 orders, telehealth delivered over 17,000 consultations, and the MAI AI-enabled companion handled over 9,600 interactions, underscoring meaningful monetization of digital services.
Network footprint growth continues via greenfield and inorganic moves: the Electronic City 50th hospital added roughly 300 beds, Nashik commissioned 103 additional beds plus a linear accelerator and PET-CT, Sahyadri contributed INR332 crores of revenue in the quarter, and the Kinder Hospital transaction will add about 100 beds in Whitefield once CPs are completed.
Healthcare Services
Hospital
89,091 Cr
Low Risk
102.0
59.5
2.7
5.4
813.70
597.80
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
Manipal Health Enterprises Ltd (MANIPALHOS) is currently trading at 672.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Manipal Health Enterprises Limited operates a national network of tertiary and quaternary hospitals, managing over fifty hospitals and more than 12,600 licensed beds across India, delivering high-acuity clinical services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics and renal sciences, while also offering diagnostics, outpatient clinics and digital healthcare capabilities. In Q1 FY27 Manipal reported consolidated revenue of INR3,091 crores, a 38% year-on-year increase, with network EBITDA of INR749 crores (+26% YoY); ex-Sahyadri operating margin was about 25% while network margin was 24.2%, driven primarily by sustained inpatient volume growth (+39%) and outpatient volumes (+26%). Digital and out-of-hospital initiatives contributed materially during the quarter: digital revenue was around INR710 crores (approximately 23% of overall revenue), e-pharmacy processed over 15,000 orders, telehealth delivered over 17,000 consultations, and the MAI AI-enabled companion handled over 9,600 interactions, underscoring meaningful monetization of digital services. Network footprint growth continues via greenfield and inorganic moves: the Electronic City 50th hospital added roughly 300 beds, Nashik commissioned 103 additional beds plus a linear accelerator and PET-CT, Sahyadri contributed INR332 crores of revenue in the quarter, and the Kinder Hospital transaction will add about 100 beds in Whitefield once CPs are completed.
Over the past 52 weeks, Manipal Health Enterprises Ltd has traded between a low of ₹597.80 and a high of ₹813.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Manipal Health Enterprises Ltd has a market capitalization of approximately 89,090.50. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Manipal Health Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 101.97 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 89,090.50 Cr, Manipal Health Enterprises Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Manipal Health Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Manipal Health Enterprises Ltd is 101.97. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Manipal Hospitals has agreed to lease approximately 3.5 acres in Gurugram, Delhi NCR, from TIL Investments Pvt Ltd. TIL Investments is an Indian subsidiary of Thakral Corporation Ltd, and the initial lease period is approximately 30 years.
The first phase of the proposed Gurugram multispecialty hospital is expected to have up to 500 beds. It will be developed on approximately 3.5 acres of land in Delhi NCR.
MEMG International India Private Limited pledged 1,44,92,951 Manipal Health shares on 24 October 2026. The filing puts this at 1.09% of fully diluted share capital, including outstanding employee stock option plan pool options.
MEMG International India Private Limited disclosed the release of pledges on 1,44,92,951 shares. The total comprises 72,50,000 shares linked to Vistra ITCL and 72,42,951 shares linked to 360 One Prime.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
8590.00 | 1,23,511 Cr | 52.86 | 11.65 | 0.23 | 21.14 | 18.94 | 9.65 | ||
925.00 | 90,033 Cr | 65.22 | 7.94 | 0.22 | 12.18 | 13.24 | 7.37 | ||
677.30 | 89,091 Cr | 101.97 | 5.42 | 0.00 | 10.59 | 9.51 | 0.00 | ||
724.10 | 63,118 Cr | 111.93 | 8.48 | 0.25 | 7.11 | 8.21 | 3.22 | ||
769.50 | 58,094 Cr | 54.71 | 5.54 | 0.13 | 9.91 | 12.56 | 6.47 | ||
1428.55 | 38,411 Cr | 62.65 | 8.88 | 0.03 | 14.30 | 16.02 | 9.28 | ||
1866.60 | 38,146 Cr | 44.12 | 7.62 | 0.24 | 17.17 | 12.26 | 6.43 | ||
| Median: 7 Co. | — | 925.00 | 63,118 Cr | 62.65 | 7.94 | 0.22 | 12.18 | 12.56 | 6.47 |
